Showing 107 results

Filters Content type: News, Editors' picks, About HIV Topic: Treatment simplification strategies

Research into HIV treatment strategies in which the number of antiretroviral drugs or frequency of dosing is reduced. Some dual therapy regimens have proven to be safe and effective.

Treatment simplification strategies

Viral suppression maintained with alternate-day dosing of efavirenz/tenofovir/emtricitabine

News
1 April 2019
Treatment simplification strategies

Two-antiretroviral maintenance failure - raltegravir regimens seem most vulnerable

Editor's pick
NATAP
29 March 2019
Treatment simplification strategies

Laura Waters, MD, FRCP: Can Two Drugs Tango?

Editor's pick
Contagion Live
12 March 2019
Injectable & long-acting HIV treatment

Long-acting injectable treatment maintains viral suppression

News
8 March 2019
Treatment simplification strategies

Early ART in HIV Possible Key to Dolutegravir Monotherapy Success

Editor's pick
Infectious Disease Advisor
15 February 2019
HIV treatment

Six advantages of dolutegravir

Editor's pick
Spotlight SA
28 January 2019
Treatment simplification strategies

Dolutegravir Monotherapy for HIV No Longer Recommended

Editor's pick
Contagion Live
9 January 2019
HIV treatment

Top 10 HIV Clinical Developments of 2018

Editor's pick
The Body Pro
20 December 2018
Pharmaceutical industry

Biktarvy's success raises doubts about ViiV's 'new era' of HIV treatment

Editor's pick
BioPharma Dive
12 December 2018
Treatment simplification strategies

Dual HIV Regimen Equaled Triple Even After Treatment Failure

Editor's pick
MD Magazine
26 November 2018
New & experimental HIV treatments

Tivicay Plus Boosted Prezista Shows Promise as Two-Drug HIV Regimen

Editor's pick
Poz
16 November 2018
Treatment simplification strategies

Dolutegravir plus darunavir maintains viral suppression without NRTIs

News
6 November 2018
Treatment simplification strategies

Two-drug protease inhibitor treatment as effective as three-drug treatment – and fewer stop due to side-effects

News
30 October 2018
Treatment simplification strategies

Studies confirm long-term effectiveness of new single-tablet regimens

News
18 October 2018
New & experimental HIV treatments

Dual-antibody combination therapy produces three to seven months of viral suppression without pills

News
8 October 2018
New & experimental HIV treatments

ViiV Healthcare submits regulatory application to European Medicines Agency for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV

Editor's pick
ViiV press release
16 September 2018
Treatment simplification strategies

What you need to know about HIV two-drug regimens

Editor's pick
BETA blog
28 August 2018
Treatment simplification strategies

Dolutegravir dual therapy works well for first-time HIV treatment

News
25 July 2018
Pharmaceutical industry

GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

Editor's pick
Reuters
25 June 2018
New & experimental HIV treatments

GSK's two-drug HIV treatment meets main goal in late stage studies

Editor's pick
Reuters
15 June 2018
How HIV works

ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

Editor's pick
Infectious Disease Advisor
15 June 2018
New & experimental HIV treatments

ViiV Healthcare reports positive results for landmark phase III studies for dolutegravir and lamivudine

Editor's pick
ViiV Healthcare press release
15 June 2018
New & experimental HIV treatments

ViiV Healthcare gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe

Editor's pick
ViiV press release
23 March 2018
New & experimental HIV treatments

ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment

Editor's pick
ViiV press release
8 February 2018